- Report
- September 2026
- 200 Pages
Europe
From €2331EUR$2,490USD£1,948GBP
- Report
- September 2026
- 200 Pages
United States
From €2331EUR$2,490USD£1,948GBP
- Report
- April 2026
- 87 Pages
United States
From €2667EUR$2,850USD£2,230GBP
- Report
- April 2026
North America
From €3229EUR$3,450USD£2,699GBP
- Report
- April 2026
Middle East, Africa
From €3229EUR$3,450USD£2,699GBP
- Report
- April 2026
Europe
From €3229EUR$3,450USD£2,699GBP
- Report
- March 2026
Middle East, Africa
From €3229EUR$3,450USD£2,699GBP
- Report
- March 2026
Europe
From €3229EUR$3,450USD£2,699GBP
- Report
- March 2026
Asia Pacific
From €3229EUR$3,450USD£2,699GBP
- Report
- July 2026
- 332 Pages
Europe
From €1404EUR$1,500USD£1,173GBP
- Report
- March 2026
- 199 Pages
United States
From €4539EUR$4,850USD£3,794GBP
- Report
- December 2025
- 150 Pages
United States
From €4539EUR$4,850USD£3,794GBP
- Report
- August 2019
- 264 Pages
Global
From €3739EUR$3,995USD£3,125GBP
- Report
- January 2022
- 249 Pages
Global
From €3510EUR$3,750USD£2,934GBP
- Report
- June 2025
- 463 Pages
Global
From €5386EUR$5,956USD£4,350GBP
- Report
- May 2025
- 483 Pages
Global
From €5386EUR$5,956USD£4,350GBP
- Report
- October 2022
- 213 Pages
Global
From €4891EUR$5,409USD£3,950GBP
- Report
- August 2019
- 488 Pages
Global
From €3743EUR$3,999USD£3,129GBP
- Report
- April 2024
- 270 Pages
Global
From €4680EUR$5,000USD£3,912GBP
- Report
- September 2023
- 60 Pages
Global
From €4680EUR$5,000USD£3,912GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more